Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre C Kalil

Showing results (1-10 of 277) with videos related to

Pageof 28
Sort By:
Critical Care Medicine|January 21, 2011
Is it time to replace L-arginine in severe sepsis?Andre C Kalil
Critical Care Medicine|December 20, 2011
Cytomegalovirus and mortality in critical care patients: another piece of the puzzleAndre C Kalil
Critical Care Medicine|July 20, 2011
Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: how should we conciliate these new findings with the Zephyr trial results?Andre C Kalil
Critical Care Medicine|September 25, 2013
Deciphering the sepsis riddle: we can learn from Star TrekAndre C Kalil
Current Opinion in Critical Care|August 2, 2021
Editorial: COVID-19: A New Severe InfectionAndre C Kalil
Critical Care Medicine|February 21, 2015
Should heparin be used to treat patients with severe sepsis?Andre C Kalil
Seminars in Respiratory and Critical Care Medicine|September 20, 2021
Sepsis and Septic ShockAndre C Kalil
The Lancet. Respiratory Medicine|February 24, 2023
Remdesivir saves lives. Were 3 years needed to learn that?Andre C Kalil
JAMA|March 26, 2020
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During PandemicsAndre C Kalil
JAMA|January 18, 2020
Lack of Benefit of High-Dose Vitamin C, Thiamine, and Hydrocortisone Combination for Patients With SepsisAndre C Kalil
Pageof 28

Showing results (1-10 of 277) with videos related to

Sort By:
Pageof 28
Critical Care Medicine|January 21, 2011
Is it time to replace L-arginine in severe sepsis?Andre C Kalil
Critical Care Medicine|December 20, 2011
Cytomegalovirus and mortality in critical care patients: another piece of the puzzleAndre C Kalil
Critical Care Medicine|July 20, 2011
Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: how should we conciliate these new findings with the Zephyr trial results?Andre C Kalil
Critical Care Medicine|September 25, 2013
Deciphering the sepsis riddle: we can learn from Star TrekAndre C Kalil
Current Opinion in Critical Care|August 2, 2021
Editorial: COVID-19: A New Severe InfectionAndre C Kalil
Critical Care Medicine|February 21, 2015
Should heparin be used to treat patients with severe sepsis?Andre C Kalil
Seminars in Respiratory and Critical Care Medicine|September 20, 2021
Sepsis and Septic ShockAndre C Kalil
The Lancet. Respiratory Medicine|February 24, 2023
Remdesivir saves lives. Were 3 years needed to learn that?Andre C Kalil
JAMA|March 26, 2020
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During PandemicsAndre C Kalil
JAMA|January 18, 2020
Lack of Benefit of High-Dose Vitamin C, Thiamine, and Hydrocortisone Combination for Patients With SepsisAndre C Kalil
Pageof 28